We are always evolving in an ever-changing industry.

Keep up-to-date with PrECOG by visiting our news page regularly.

PrE0204 – Published

The results from the PrE0204 trial, A Multi-Institutional, Single Arm, Two-Stage Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma was published by Sahai V, Catalano P, Zalupski MM, et.al. The article appeared online before print in JAMA Oncology on Aug 30, 2018. [NCT02181634, doi: 10.1001/jamaoncol.2018.3277].